Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders.

Molecular cell | Mar 17, 2006

http://www.ncbi.nlm.nih.gov/pubmed/16543147

X-linked inhibitor of apoptosis (XIAP), known primarily for its caspase inhibitory properties, has recently been shown to interact with and regulate the levels of COMMD1, a protein associated with a form of canine copper toxicosis. Here, we describe a role for XIAP in copper metabolism. We find that XIAP levels are greatly reduced by intracellular copper accumulation in Wilson's disease and other copper toxicosis disorders and in cells cultured under high copper conditions. Elevated copper levels result in a profound, reversible conformational change in XIAP due to the direct binding of copper to XIAP, which accelerates its degradation and significantly decreases its ability to inhibit caspase-3. This results in a lowering of the apoptotic threshold, sensitizing the cell to apoptosis. These data provide an unsuspected link between copper homeostasis and the regulation of cell death through XIAP and may contribute to the pathophysiology of copper toxicosis disorders.

Pubmed ID: 16543147 RIS Download

Mesh terms: Apoptosis | Carrier Proteins | Caspase 3 | Caspases | Cell Line | Copper | Electrophoretic Mobility Shift Assay | Hepatolenticular Degeneration | Humans | Inhibitor of Apoptosis Proteins | Models, Biological | Protein Conformation | Signal Transduction | Transfection | X-Linked Inhibitor of Apoptosis Protein

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.